217 related articles for article (PubMed ID: 33555057)
1. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia.
Onita T; Ishihara N; Ikebuchi A; Yano T; Nishimura N; Tamaki H; Ikawa K; Morikawa N; Naora K
J Clin Pharm Ther; 2022 Dec; 47(12):2041-2048. PubMed ID: 35893441
[TBL] [Abstract][Full Text] [Related]
3. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
[TBL] [Abstract][Full Text] [Related]
4. Linezolid-induced haematological toxicity.
Moraza L; Leache L; Aquerreta I; Ortega A
Farm Hosp; 2015 Nov; 39(6):320-6. PubMed ID: 26618376
[TBL] [Abstract][Full Text] [Related]
5. Association of clinical factors with thrombocytopenia in patients receiving linezolid treatment: a retrospective study.
Thi Phuong Thao L; Duc Trung N; Thi My L; Minh Hong L; Viet Hoan B; Quang Hung V; Dang Hai P
J Infect Dev Ctries; 2024 Feb; 18(2):285-290. PubMed ID: 38484357
[TBL] [Abstract][Full Text] [Related]
6. Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days.
Sato Y; Iguchi M; Kato Y; Morioka H; Hirabayashi A; Tetsuka N; Tomita Y; Kato D; Yamada K; Kimura H; Yagi T
Nagoya J Med Sci; 2020 Aug; 82(3):407-414. PubMed ID: 33132425
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for development of hematotoxicity in elderly patients treated with Linezolid].
Bo SY; Su AM; Yang F; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):533-538. PubMed ID: 35658376
[No Abstract] [Full Text] [Related]
8. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia.
Tanaka R; Suzuki Y; Morinaga Y; Iwao M; Takumi Y; Hashinaga K; Tatsuta R; Hiramatsu K; Kadota JI; Itoh H
J Clin Pharm Ther; 2021 Apr; 46(2):343-351. PubMed ID: 33016566
[TBL] [Abstract][Full Text] [Related]
9. Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case-control study.
Chen C; Li Y; Yu J; Qian S
Clin Transl Oncol; 2022 Mar; 24(3):540-545. PubMed ID: 34716540
[TBL] [Abstract][Full Text] [Related]
10. A risk factor-based predictive model for linezolid-induced anaemia: A 7-year retrospective study.
Qin Y; Liu Y; Chen Z; Cao M; Shen Y; Ye Y
J Clin Pharm Ther; 2021 Dec; 46(6):1591-1599. PubMed ID: 34287998
[TBL] [Abstract][Full Text] [Related]
11. Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.
Tajima M; Kato Y; Matsumoto J; Hirosawa I; Suzuki M; Takashio Y; Yamamoto M; Nishi Y; Yamada H
Biol Pharm Bull; 2016; 39(11):1846-1851. PubMed ID: 27803456
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for thrombocytopenia in adult chinese patients receiving linezolid therapy.
Chen C; Guo DH; Cao X; Cai Y; Xu Y; Zhu M; Ma L
Curr Ther Res Clin Exp; 2012 Dec; 73(6):195-206. PubMed ID: 24653521
[TBL] [Abstract][Full Text] [Related]
13. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with high linezolid trough plasma concentrations.
Morata L; De la Calle C; Gómez-Cerquera JM; Manzanedo L; Casals G; Brunet M; Cobos-Trigueros N; Martínez JA; Mensa J; Soriano A
Expert Opin Pharmacother; 2016 Jun; 17(9):1183-7. PubMed ID: 27156708
[TBL] [Abstract][Full Text] [Related]
15. Predictive score of haematological toxicity in patients treated with linezolid.
González-Del Castillo J; Candel FJ; Manzano-Lorenzo R; Arias L; García-Lamberechts EJ; Martín-Sánchez FJ;
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1511-1517. PubMed ID: 28343274
[TBL] [Abstract][Full Text] [Related]
16. [Translated article] Influence of augmented renal clearance in the lower incidence of linezolid-related haematological toxicity.
Sánchez-Sanz B; Caro-Teller JM; González-Barrios I; Rodríguez-Quesada PP; Hernández-Ramos JA; Ferrari-Piquero JM
Farm Hosp; 2023; 47(5):T190-T195. PubMed ID: 37679220
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
Mori N; Kamimura Y; Kimura Y; Hirose S; Aoki Y; Bito S
Eur J Clin Pharmacol; 2018 Apr; 74(4):405-411. PubMed ID: 29222713
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia in Patients Receiving Prolonged Linezolid May be Caused by Oxidative Stress.
Wang TL; Guo DH; Bai Y; Wen K; Han WY; Wang R
Clin Drug Investig; 2016 Jan; 36(1):67-75. PubMed ID: 26507619
[TBL] [Abstract][Full Text] [Related]
19. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
[TBL] [Abstract][Full Text] [Related]
20. Effect of linezolid on platelet count in critically ill patients with thrombocytopenia.
Tatsumi H; Akatsuka M; Kuroda H; Kazuma S; Suzuki S; Masuda Y
PLoS One; 2023; 18(6):e0286088. PubMed ID: 37384758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]